senate Bill S6306A

2021-2022 Legislative Session

Relates to determining whether the state can claim federal financial participation for coverage of and payment for certain evidence-based mobile medical applications

download bill text pdf

Sponsored By

Current Bill Status - In Senate Committee Health Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (3)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Aug 02, 2021 print number 6306a
Aug 02, 2021 amend (t) and recommit to health
Apr 21, 2021 referred to health

S6306 - Details

Current Committee:
Senate Health
Law Section:
Medical Assistance

S6306 - Summary

Directs the department of health to request guidance from the Centers for Medicare and Medicaid Services to determine whether the state can claim federal financial participation for coverage of and payment for certain evidence-based mobile medical applications.

S6306 - Sponsor Memo

S6306 - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   6306
 
                        2021-2022 Regular Sessions
 
                             I N  S E N A T E
 
                              April 21, 2021
                                ___________
 
 Introduced  by Sen. HARCKHAM -- read twice and ordered printed, and when
   printed to be committed to the Committee on Health
 
 AN ACT in relation to determining whether the state  can  claim  federal
   financial  participation  for  coverage  of  and  payment  for certain
   evidence-based smartphone apps

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Legislative finding and declaration. New Yorkers in recov-
 ery for substance and opioid use disorders and in treatment  for  mental
 health  conditions  are  losing  access to in-person treatment under the
 state's "stay at home" and social distancing orders as part of coronavi-
 rus pandemic mitigation efforts. In recent news  reports,  experts  warn
 that  the  coronavirus  pandemic may be "a national relapse trigger" for
 individuals in treatment for alcohol, cocaine, methamphetamine, marijua-
 na, and heroin addiction.  Evidence-based smartphone apps are new, soft-
 ware-based disease treatments designed to directly treat disease, tested
 for safety and efficacy in randomized clinical trials, evaluated by  the
 FDA,  and  prescribed  by  healthcare  providers.  These  therapies  are
 designed and tested much like traditional prescription  drugs  with  one
 distinction:  rather  than  swallowing  a  pill  or taking an injection,
 patients are treated with software.  Certain  evidence-based  smartphone
 apps  provide  clinicians and patients with evidence-based remote treat-
 ment modalities to treat substance  and  opioid  use  disorders,  mental
 health,  and  other  diseases and conditions. However, there is no clear
 statutory benefit category to allow Medicaid coverage for evidence-based
 smartphone apps.  In light of the promise of  evidence-based  smartphone
 apps  for  the  treatment  of patients with substance use and opioid use
 disorders  during  the  coronavirus  pandemic,  this  legislation  would
 require  that the New York state department of health seek guidance from
 the Centers for Medicare and Medicaid Services relative  to  a  coverage
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD10469-01-1

S6306A (ACTIVE) - Details

Current Committee:
Senate Health
Law Section:
Medical Assistance

S6306A (ACTIVE) - Summary

Directs the department of health to request guidance from the Centers for Medicare and Medicaid Services to determine whether the state can claim federal financial participation for coverage of and payment for certain evidence-based mobile medical applications.

S6306A (ACTIVE) - Sponsor Memo

S6306A (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  6306--A
 
                        2021-2022 Regular Sessions
 
                             I N  S E N A T E
 
                              April 21, 2021
                                ___________
 
 Introduced  by Sen. HARCKHAM -- read twice and ordered printed, and when
   printed to be committed  to  the  Committee  on  Health  --  committee
   discharged, bill amended, ordered reprinted as amended and recommitted
   to said committee
 
 AN  ACT  in  relation to determining whether the state can claim federal
   financial participation  for  coverage  of  and  payment  for  certain
   evidence-based mobile medical applications
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Legislative finding and declaration. New Yorkers in  recov-
 ery  for  substance and opioid use disorders and in treatment for mental
 health conditions are losing access to  in-person  treatment  under  the
 state's "stay at home" and social distancing orders as part of coronavi-
 rus  pandemic  mitigation  efforts. In recent news reports, experts warn
 that the coronavirus pandemic may be "a national  relapse  trigger"  for
 individuals in treatment for alcohol, cocaine, methamphetamine, marijua-
 na,  and  heroin addiction.   Evidence-based mobile medical applications
 are new, software-based disease treatments designed  to  directly  treat
 disease,  tested  for safety and efficacy in randomized clinical trials,
 evaluated by the FDA, and  prescribed  by  healthcare  providers.  These
 therapies  are  designed  and  tested much like traditional prescription
 drugs with one distinction: rather than swallowing a pill or  taking  an
 injection,  patients  are  treated with software. Certain evidence-based
 mobile  medical  applications  provide  clinicians  and  patients   with
 evidence-based remote treatment modalities to treat substance and opioid
 use  disorders, mental health, and other diseases and conditions. Howev-
 er, there is no clear  statutory  benefit  category  to  allow  Medicaid
 coverage  for  evidence-based  mobile medical applications.  In light of
 the promise of evidence-based mobile medical applications for the treat-
 ment of patients with substance use and opioid use disorders during  the
 coronavirus  pandemic,  this legislation would require that the New York
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.